tenk.fyi

BioAtla, Inc.

BCABNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$69.8M

43.5% YoY

EPS

$-1.44

44.2% YoY

Cash

$49.0M

56.0% YoY

FY 2024 · As of 2024-12-31